Results of SUMMIT: a global phII trial of neratinib in HER2/3 mutant solid tumours

Neratinib in HER2 or HER3 mutant solid tumours

75 years of Tata Memorial Centre

SBRT or surgery for early lung cancer?

Perspectives on cervical cancer guidelines and vaccination in India

Community engagement and cancer vaccination in India

Translational research and treating resistance

Radiotherapy at Tata Memorial Hospital

Mechanisms of resistance in triple negative breast cancer

De-escalating and escalating surgery in the management of early breast cancer

Personalising breast cancer therapies

Editor's Choice for March 2017